1. Nassar A. Core needle biopsy versus fine needle aspiration biopsy in breast--a historical perspective and opportunities in the modern era. Diagn Cytopathol. 2011;39(5):380-8.

2. Łukasiewicz E, Ziemiecka A, Jakubowski W, Vojinovic J, Bogucevska M, Dobruch-Sobczak K. Fine-needle versus core-needle biopsy - which one to choose in preoperative assessment of focal lesions in the breasts? Literature review. J Ultrason. 2017;17(71):267-74.

3. Shooshtarizadeh T, Mehrazma M, Haji Aliloo Sami S, Kabir A. A Prospective study of the diagnostic value of core needle biopsy and fine needle aspiration in bone and soft tissue lesions. RJMS. 2004;11(41): 433-9.

4. Triantafillidou, ES. Enhancing the critical role of core needle biopsy in breast Cancer. Hellenic J Surg. 2020; 92(2):76-84.

5. Ha EJ, Baek JH, Lee JH, Kim JK, Song DE, Kim WB, et al. Core needle biopsy could reduce diagnostic surgery in patients with anaplastic thyroid cancer or thyroid lymphoma. Eur Radiol. 2016;26(4):1031-6.

6. Abba AA, Khalil MZ. Clinical approach to lymphadenopathy. Ann Niger Med. 2012;6(1):11-7.

7. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group [see comments]. Blood. 1994;84(5):1361-92.

9. Halliday T, Baxter G. Lymphoma: pictorial review. I. Eur Radiol. 2003;13(5):1154-64.

10. Loubeyre P, McKee TA, Copercini M, Rosset A, Dietrich P-Y. Diagnostic precision of image-guided multisampling core needle biopsy of suspected lymphomas in a primary care hospital. Br J Cancer. 2009;100(11):1771-6.

11. Pfeiffer J, Kayser G, Ridder GJ. Sonography‐assisted cutting needle biopsy in the head and neck for the diagnosis of lymphoma: can it replace lymph node extirpation?. Laryngoscope. 2009;119(4):689-95.

12. Hu Q, Naushad H, Xie Q, Al-Howaidi I, Wang M, Fu K. Needle-core biopsy in the pathologic diagnosis of malignant lymphoma showing high reproducibility among pathologists. Am J Clin Pathol. 2013;140(2):238-47.

13. Kiliçarslan A, Doğan M, Süngü N, Karakök E, Karabekmez L, Akyol M, Doğan HT. Can cutting-needle biopsy be an alternative to excisional biopsy in lymph node pathologies?. Turk Patoloji Derg. 2017;1(1):235-9.

14. Hahn SY, Shin JH, Oh YL, Park KW, Lim Y. Comparison between fine needle aspiration and core needle biopsy for the diagnosis of thyroid nodules: effective indications according to US findings. Sci Rep. 2020;10(1):4969.

15. Loganathan AK, Jacob TJ, Matthew LG, Moses V, Keshava SKN, Priscilla AJ, Kurian JJ. Efficacy of core needle biopsy in the diagnosis of pediatric extracranial solid malignancies: a 10-year study. J Indian Assoc Pediatr Surg. 2022;27(1):60-4.

16. de Kerviler E, de Bazelaire C, Mounier N, Mathieu O, Brethon B, Brière J, et al. Image-guided core-needle biopsy of peripheral lymph nodes allows the diagnosis of lymphomas. Eur Radiol. 2007;17(3):843-9.

17. Christine M, Denison, Lester SC. A comprehensive guide to core needle biopsies of the breast. IN: Shin SJ, Editors. Essential components of a successful breast core needle biopsy program: imaging modalities, sampling techniques, specimen processing, radiologic/pathologic correlation, and appropriate follow-up. 1st ed. New York: Springer, 2016: 3-47.

18. Hristu R, Stanciu SG, Dumitru A, Paun B, Floroiu I, Costache M, Stanciu GA. Influence of hematoxylin and eosin staining on the quantitative analysis of second harmonic generation imaging of fixed tissue sections. Biomed Opt Express. 2021;12(9):5829-43.

19. Hawes D, Shi SR, Dabbs DJ, Taylor CR, Cote RJ. Immunohistochemistry. Mod Surg Pathol. 2009: 48-70.

20. Das DK. Contribution of immunocytochemistry to the diagnosis of usual and unusual lymphoma cases. J Cytol. 2018;35(3):163-9.

21. Higgins RA, Blankenship JE, Kinney MC. Application of immunohistochemistry in the diagnosis of non-Hodgkin and Hodgkin lymphoma. Arch Pathol Lab Med. 2008;132(3):441-61.

22. Baratloo A, safari S, Elfil M, Negida A. Evidence based emergency medicine part 3: positive and negative likelihood ratios of diagnostic tests. Emergency (2015); 3 (4): 170-171.

23. Yaseri M, Yekaninejad M, Pakpour A, Rahmani S, Rangin H, Akaberi A. Self-learning concepts of diagnostic tests by graphical approach: sensitivity, specificity, positive predictive value and negative predictive value. J North Khorasan Univ Med Sci. 2012;4(2):275-82.

24. Elhamdoust E, Motamedfar A, Gharibvand MM, Jazayeri SN. Investigation of the value of ultrasound-guided core needle biopsy from pathologic lymph nodes to the diagnosis of lymphoma. J Family Med Prim Care. 2020;9(6):2801-5.

25. Abdolsamadi H, Bakianian Vaziri P. Evaluation of frequency of lymphoma at the teaching hospitals of Hamadan city during 1993-2003. Avicenna J Clin Med. 2007;13 (4):64-8.

26. Tahmasebi B, Mahmoudi M, Yahyapour Y, Jamshidi M, Holakouei Naeini K. Determination and comparison of incidence rate and trend of morbidity of leukemia and lymphoma in Mazandaran province (1376-1382). J Mazandaran Univ Med Sci. 2006; 16(54): 87-9.

27. Cheng Z, Liang P. US-guided core needle biopsy under assistance of hydrodissection to diagnose small lymph node metastases adjacent to cervical large vessels. Diagn Interv Radiol. 2019;25(2):122-6.

28. Horn LC, Bilek K, Fischer U, Einenkel J, Hentschel B. A cut-off value of 2 cm in tumor size is of prognostic value in surgically treated FIGO stage IB cervical cancer. Gynecol Oncol. 2014;134(1):42-6.

29. Cheong O, Oh ST, Kim BS, Yook JH, Kim JH, Im JT, Park GC. Large metastatic lymph node size, especially more than 2 cm: independent predictor of poor prognosis in node-positive gastric carcinoma. World J Surg. 2008;32(2):262-6.

30. He Y, Ji X, Xie Y, He B, Xu X, Chen X, et al. Clinical application of ultrasound-guided core needle biopsy with multiple punches in the diagnosis of lymphoma. World J Surg Oncol. 2015 27;13:126.

31. Harrysson S, Eloranta S, Ekberg S, Enblad G, Jerkeman M, Wahlin BE, et al. Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden. Blood Cancer J. 2021;11(1):9.

32. Skelton E, Jewison A, Okpaluba C, Sallomi J, Lowe J, Ramesar K, Grace R, Howlett DC. Image-guided core needle biopsy in the diagnosis of malignant lymphoma. Eur J Surg Oncol. 2015;41(7):852-8.

33. Chatani S, Hasegawa T, Kato S, Murata S, Sato Y, Yamaura H, Yamamoto K, et al. Image-guided core needle biopsy in the diagnosis of malignant lymphoma: comparison with surgical excision biopsy. Eur J Radiol. 2020;127 (2020):108990.

34. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006;107(1):265-76.

35. Burkhardt B, Zimmermann M, Oschlies I, Niggli F, Mann G, Parwaresch R, et al. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol. 2005;131(1):39-49.

36. Davidson T, Ravid MM, Nissan E, Sklair-Levy M, Nissan J, Chikman B. Correlations between core needle biopsy and excisional biopsy findings in suspected breast lesions: a single center study. Isr Med Assoc J. 2018;20(7):401-4.

37. Sun C, Lu Q, Zhang X, Zhang Y, Jia S, Wang J, et al. Comparison between core needle biopsy and excisional biopsy for breast neoplasm. Medicine (Baltimore). 2021 27;100(34):e26970.

38. Lo TH, Wang CP, Chen CN, Yang TL, Lou PJ, Ko JY, Chang YL, Chen TC. Diagnostic performance of core needle biopsy for nodal recurrences in patients with head and neck squamous cell carcinoma. Sci Rep. 2022;12(1):2048.

39. Ahn HS, Youn I, Na DG, Kim SJ, Lee MY. Diagnostic performance of core needle biopsy as a first-line diagnostic tool for thyroid nodules according to ultrasound patterns: comparison with fine needle aspiration using propensity score matching analysis. Clin Endocrinol (Oxf). 2021;94(3):494-503.